TAPI offers customized CDMO Solutions for API development and manufacturing services.
01 1Teva API India Private Ltd
02 1Aurobindo Pharma Limited
03 2F.I.S. FABBRICA ITALIANA SINTETICI SPA
04 1Hetero Drugs Limited
05 2MYLAN LABORATORIES LIMITED
06 1Tianish Laboratories Private Limited
07 1Yung Shin Pharmaceutical Ind. Co., Ltd.
01 3ELETRIPTAN HYDROBROMIDE
02 2ELETRIPTAN HYDROBROMIDE (BETA FORM)
03 3Eletriptan Hydrobromide
04 1Eletriptan Hydrobromide IH
01 1China
02 3India
03 1Israel
04 2Italy
05 2U.S.A
TAPI offers customized CDMO Solutions for API development and manufacturing services.
NDC Package Code : 15894-0031
Start Marketing Date : 2016-05-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-101
Start Marketing Date : 2023-12-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0102
Start Marketing Date : 2012-10-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0090
Start Marketing Date : 2010-03-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0059
Start Marketing Date : 2002-12-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0037
Start Marketing Date : 2024-08-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-719
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-790
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63126-904
Start Marketing Date : 2015-09-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Eletriptan Hydrobromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eletriptan Hydrobromide, including repackagers and relabelers. The FDA regulates Eletriptan Hydrobromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eletriptan Hydrobromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eletriptan Hydrobromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eletriptan Hydrobromide supplier is an individual or a company that provides Eletriptan Hydrobromide active pharmaceutical ingredient (API) or Eletriptan Hydrobromide finished formulations upon request. The Eletriptan Hydrobromide suppliers may include Eletriptan Hydrobromide API manufacturers, exporters, distributors and traders.
click here to find a list of Eletriptan Hydrobromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eletriptan Hydrobromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eletriptan Hydrobromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eletriptan Hydrobromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eletriptan Hydrobromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eletriptan Hydrobromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eletriptan Hydrobromide suppliers with NDC on PharmaCompass.
We have 7 companies offering Eletriptan Hydrobromide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
